Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 Dose Response on Myocardial Metabolism
NCT01607450Phase 3Completed
- Sponsor
- Indiana University
- Start
- May 2010
- Primary completion
- Dec 2012
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Glucagon-like peptide 1 in type 2 diabetes mellitus (T2DM), sponsored by Indiana University. Started May 2010; status: completed.
02
Drugs
Glucagon-like peptide 1
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01607450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01607450.